Skip to content

Breathing Counts: Evaluating Adherence in the Presence of Asthma Navigation Support

Breathing Counts: Evaluating Adherence in the Presence of Asthma Navigation Support

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03065205
Enrollment
65
Registered
2017-02-27
Start date
2017-02-16
Completion date
2018-06-30
Last updated
2019-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Brief summary

To determine if an asthma navigator is helpful in improving communication between care providers and improving patient adherence to asthma medications after an asthma exacerbation.

Detailed description

This study will aim to use technology to evaluate the effectiveness of a patient navigator for childhood asthma. The Investigators will place adherence monitoring devices on patient inhalers, and track use of patient asthma medicines. The Investigators will also utilize an asthma navigator who will discuss adherence with families and help to address any barriers to adherence that families identify. Additionally, the navigator will communicate patient specific adherence information to the patient's primary care physician (PCP) and school nurse. The adherence monitor will monitor communications between these providers.

Interventions

DEVICEPropeller Health device + asthma navigator

The patients will be monitored using the propeller health device for 6 months. The patients will be contacted at 2 month intervals by an asthma health educator to discuss barriers to adherence to asthma medications

Sponsors

University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Age 6-17 years old, * Admission to Children's Hospital Colorado with an asthma exacerbation between Jan 1 2017 and Dec 31 2017.

Exclusion criteria

* Language other than English or Spanish (application for monitoring adherence is only available in these languages) * Presence of other complex medical problems including: * Cystic Fibrosis, * Tracheostomy/ventilator dependence, * other severe chronic lung disease, and * significant developmental delays. * Home schooled or not in school * Following up with an allergy or pulmonary provider outside the CHCO system after hospital discharge.

Design outcomes

Primary

MeasureTime frameDescription
Change in Adherence of Use of Patient Asthma InhalersWeek 1 to Week 24Adherence will be measured via adherence monitoring devices for 6 months per patient. Change in device measured adherence from week 1 to week 24. Measured as change in average number of puffs of controller medication taken/puffs individually prescribed, measured between weeks 1 and 24.

Secondary

MeasureTime frameDescription
Degree of Asthma Control6 monthsMeasured via questionnaire data using Asthma Control Test (ACT) or Childhood Asthma Control Test (cACT) every 2 months. Reported at 6 months. Scores range from 5-25 on the ACT and 0-27 on the cACT. Scores \>19 on either test indicate good asthma control
Barriers to Adherence of Patient Asthma Inhalers6 monthsMeasured via questionnaire data obtained every 2 months. Reported at 6 months.
Effectiveness of Communication Between Providers6 monthsmeasured via survey to providers at the end of the intervention

Countries

United States

Participant flow

Participants by arm

ArmCount
Single Arm
Patients will have adherence monitoring devices placed on their asthma inhalers (both daily and rescue medication). Adherence information will be sent to their PCP, specialist and school nurse monthly. Additionally, the navigator will speak with families every 2 months to discuss adherence data and address barriers. Propeller Health device + asthma navigator: The patients will be monitored using the propeller health device for 6 months. The patients will be contacted at 2 month intervals by an asthma health educator to discuss barriers to adherence to asthma medications
65
Total65

Baseline characteristics

CharacteristicSingle Arm
Age, Continuous9.08 years
STANDARD_DEVIATION 2.51
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
Race (NIH/OMB)
Asian
1 Participants
Race (NIH/OMB)
Black or African American
23 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
22 Participants
Race (NIH/OMB)
White
18 Participants
Sex: Female, Male
Female
31 Participants
Sex: Female, Male
Male
34 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 65
other
Total, other adverse events
0 / 65
serious
Total, serious adverse events
0 / 65

Outcome results

Primary

Change in Adherence of Use of Patient Asthma Inhalers

Adherence will be measured via adherence monitoring devices for 6 months per patient. Change in device measured adherence from week 1 to week 24. Measured as change in average number of puffs of controller medication taken/puffs individually prescribed, measured between weeks 1 and 24.

Time frame: Week 1 to Week 24

Population: Participants who were in the study for the 6 month period and had analyzable study data for at least 16 weeks of monitored time.

ArmMeasureValue (MEDIAN)
Single ArmChange in Adherence of Use of Patient Asthma Inhalers-0.36 Change in puffs taken/prescribed per wk
Secondary

Barriers to Adherence of Patient Asthma Inhalers

Measured via questionnaire data obtained every 2 months. Reported at 6 months.

Time frame: 6 months

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Single ArmBarriers to Adherence of Patient Asthma InhalersForgot15 Participants
Single ArmBarriers to Adherence of Patient Asthma InhalersFelt child was better3 Participants
Single ArmBarriers to Adherence of Patient Asthma InhalersThought child didn't need it2 Participants
Single ArmBarriers to Adherence of Patient Asthma InhalersAfraid inhaler could lead to addiction1 Participants
Single ArmBarriers to Adherence of Patient Asthma InhalersAfraid inhaler could damage child1 Participants
Single ArmBarriers to Adherence of Patient Asthma InhalersSide effects of inhaler1 Participants
Single ArmBarriers to Adherence of Patient Asthma InhalersInhaler not helping child1 Participants
Single ArmBarriers to Adherence of Patient Asthma InhalersDidn't understand doctor's instructions0 Participants
Single ArmBarriers to Adherence of Patient Asthma InhalersThought method of application was too complicated0 Participants
Single ArmBarriers to Adherence of Patient Asthma InhalersChild not cooperating with administration4 Participants
Single ArmBarriers to Adherence of Patient Asthma InhalersInhaler empty4 Participants
Single ArmBarriers to Adherence of Patient Asthma InhalersOther reasons16 Participants
Secondary

Degree of Asthma Control

Measured via questionnaire data using Asthma Control Test (ACT) or Childhood Asthma Control Test (cACT) every 2 months. Reported at 6 months. Scores range from 5-25 on the ACT and 0-27 on the cACT. Scores \>19 on either test indicate good asthma control

Time frame: 6 months

Population: Total number of participants who responded to the 6 month survey.

ArmMeasureGroupValue (MEAN)Dispersion
Single ArmDegree of Asthma ControlMean ACT score20.6 score on a scaleStandard Deviation 5.4
Single ArmDegree of Asthma ControlMean cACT score23.81 score on a scaleStandard Deviation 3.23
Secondary

Effectiveness of Communication Between Providers

measured via survey to providers at the end of the intervention

Time frame: 6 months

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Single ArmEffectiveness of Communication Between ProvidersCommunication increased due to study1 Participants
Single ArmEffectiveness of Communication Between ProvidersCommunicated with other providers once or twice4 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026